Money FDA approves first treatment that delays Type 1 diabetes. Why it could be ‘game changing’ November 18, 2022November 18, 2022 Adrianna Rodriguez, USA TODAY Comments Off on FDA approves first treatment that delays Type 1 diabetes. Why it could be ‘game changing’ A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of lifesaving insulin for people with diabetes.